2021
DOI: 10.1177/10556656211002675
|View full text |Cite|
|
Sign up to set email alerts
|

Estimating Craniofacial Growth Cessation: Comparison of Asymptote- and Rate-Based Methods

Abstract: Objective: To identify differences between asymptote- and rate-based methods for estimating age and size at growth cessation in linear craniofacial measurements. Design: This is a retrospective, longitudinal study. Five linear measurements were collected from lateral cephalograms as part of the Craniofacial Growth Consortium Study (CGCS). Four estimates of growth cessation, including 2 asymptote- (GCasym, GCerr) and 2 rate-based (GCabs, GC10%) methods, from double logistic models of craniofacial growth were co… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
4
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
5
1

Relationship

1
5

Authors

Journals

citations
Cited by 6 publications
(4 citation statements)
references
References 20 publications
0
4
0
Order By: Relevance
“…Age at peak growth velocity (aPGV), the mean, fifth percentile, and 95th percentile trait value at peak growth velocity (mean: sPGV), rate of growth at peak growth velocity (PGV), and the percentage of growth complete at peak growth velocity (gPGV) are estimated from posterior distributions. Growth cessation is defined as the age at which the model reaches 98% of the adult size asymptote (Hardin et al, 2021), equal to the sum of f , f TC , and a TC . Age at growth cessation (aGC), the mean, fifth percentile, and 95th percentile trait values at growth cessation (mean: sGC), growth rate at growth cessation (rGC), and the percentage of growth complete at growth cessation (gGC) were estimated from posterior distributions.…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…Age at peak growth velocity (aPGV), the mean, fifth percentile, and 95th percentile trait value at peak growth velocity (mean: sPGV), rate of growth at peak growth velocity (PGV), and the percentage of growth complete at peak growth velocity (gPGV) are estimated from posterior distributions. Growth cessation is defined as the age at which the model reaches 98% of the adult size asymptote (Hardin et al, 2021), equal to the sum of f , f TC , and a TC . Age at growth cessation (aGC), the mean, fifth percentile, and 95th percentile trait values at growth cessation (mean: sGC), growth rate at growth cessation (rGC), and the percentage of growth complete at growth cessation (gGC) were estimated from posterior distributions.…”
Section: Methodsmentioning
confidence: 99%
“…These conflicting results could stem from a number of differences in study design and, in particular, how growth cessation is estimated. Hardin et al (2021) provide an assessment of how different methods and definitions of growth cessation can influence estimates of this milestone.…”
Section: Timing Of Growth and Treatmentmentioning
confidence: 99%
“…The function of the upper molars (M 1 and M 2 ) related to masticatory activity is associated with the transfer of strains through these teeth to specific areas of the facial skeleton, which may affect the formation of their massiveness until the end of the facial skeleton growth process (potentially to 25 years—e.g., for posterior facial height—see [ 104 ]). This means that in a given individual, e.g., a male aged around 25 years, the average working time of M 1 is already about 19 years and in the case of M 2 13 years (the average age of M 1 eruption is 6 years and for M 2 —12 years—[ 68 ]; more precisely for African females: M 1 —5.4 years, M 2 —9.8 years and African males: M 1 —5.1 years; M 2 —10.5 years; Australian females: M 1 —6.5 years, M 2 —12.3 years and Australian males M 1 —6.7 years, M 2 —12.7 years [ 105 , 106 ]).…”
Section: Discussionmentioning
confidence: 99%
“…Most of the included studies had an average subject age above 20, with few including teenage patients. Although craniofacial growth can last up to 24 years old in some individuals [37], since the time intervals between pre-and post-SARPE radiographs of the included studies are within six months, with most of them even a few weeks apart, the influence of growth in the current evaluation, if any, is probably negligible.…”
Section: Limitationsmentioning
confidence: 99%